Cidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $36.00
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) had its price objective lifted by stock analysts at Needham & Company LLC from $35.00 to $36.00 in a research report issued on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Needham & Company LLC’s price objective would suggest a potential upside […]
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) had its price objective lifted by stock analysts at Needham & Company LLC from $35.00 to $36.00 in a research report issued on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Needham & Company LLC’s price objective would suggest a potential upside […]
